K
53
2
BIIB
26
2
AXP
66
2
HCP
58
4
TDC
75
4
ORLY
53
-3
NI
75
2
L
62
2
COF
55
-3
VRSK
73
5
AVGO
20
-5
MTB
63
-2
DE
46
3
PEP
41
6
MS
74
-2
VRSN
53
3
NTAP
64
2
IFF
53
2
UPS
41
-4
ABT
57
-5
K
53
2
BIIB
26
2
AXP
66
2
HCP
58
4
TDC
75
4
ORLY
53
-3
NI
75
2
L
62
2
COF
55
-3
VRSK
73
5
AVGO
20
-5
MTB
63
-2
DE
46
3
PEP
41
6
MS
74
-2
VRSN
53
3
NTAP
64
2
IFF
53
2
UPS
41
-4
ABT
57
-5
Financhill
Back

Palisade Bio 10K Form

Sell
26

PALI
Palisade Bio

Last Price:
2.47
Seasonality Move:
4.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PALI News And Ratings

See the #1 stock for the next 7 days that we like better than PALI

PALI Financial Statistics

Sales & Book Value

Annual Sales: $250K
Cash Flow: $-3.13M
Price / Cash Flow: 0
Annual Sales: $4.72
Price / Book: 0.55

Profitability

EPS (TTM): -13.99000
Net Income (TTM): $-14.07M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Palisade Bio Earnings Forecast

Key Palisade Bio Financial Ratios

  • The Research & Development expenses have been 2,757.20% of Revenue.
  • The Interest Expense is -0.12% of Operating Income.
  • The Net Earning history of PALI is -4,920.00% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 3 years.

Palisade Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PALI
Website: palisadebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PALI Technical Analysis vs Fundamental Analysis

Sell
26
Palisade Bio (PALI) is a Sell

Is Palisade Bio a Buy or a Sell?

  • Palisade Bio stock is rated a Sell
    The current Palisade Bio [PALI] share price is $2.44. The Score for PALI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.